Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Mona-Gekanju Toeque"'
Autor:
Francis Mupeta, Suilanji Sivile, Mona-Gekanju Toeque, Sombo Fwoloshi, Paul Msanzya Zulu, Duncan Chanda, Nyuma Mbewe, Mundia Mwitumwa, Chitalu Chanda, Nyakulira Kandiwo, Luunga Ziko, Tilele Mwansa, Peter Matibula, Anchidinka Mugala, Edward C. Traver, Ravi K. Tripathi, Emily L. Heil, Devang M. Patel, David J. Riedel, Lottie Hachaambwa, Lloyd Mulenga, Cassidy W. Claassen
Publikováno v:
Annals of Global Health, Vol 89, Iss 1, Pp 52-52 (2023)
The global health exchange program between the University Teaching Hospitals (UTH) of Lusaka, Zambia and the University of Maryland, Baltimore (UMB) has been operating since 2015. As trainees and facilitators of this exchange program, we describe our
Externí odkaz:
https://doaj.org/article/bf5fb34482ab46d5b1f153683b28ad16
Autor:
Brianna R. Lindsay, Linah Mwango, Mona‐Gekanju Toeque, Siphiwe Lucy Malupande, Elizabeth Nkhuwa, Clement Nchimunya Moonga, Andrew Chilambe, Henry Sakala, Ina Kafunda, Pawel Olowski, Adebayo Olufunso, Jackson Okuku, Nzali Kancheya, Daliso Mumba, Lottie Hachaambwa, Robb Sheneberger, Natalia Blanco, Marie‐Claude Lavoie, Cassidy W. Claassen
Publikováno v:
Journal of the International AIDS Society, Vol 25, Iss 11, Pp n/a-n/a (2022)
Abstract Introduction Zambia has made tremendous progress towards HIV epidemic control; however, gaps remain among key populations (KPs), such as female sex workers (FSWs), men who have sex with men (MSM), people who inject drugs (PWID) and people in
Externí odkaz:
https://doaj.org/article/2ed6b4a07fe84ce19298b21a1e1e7b9b
Autor:
Linah Mwango, Mona‐Gekanju Toeque, Brianna Lindsay, Kalima Tembo, Henry Sakala, Sean Reggee, Sibusiso Mimi Malunga, McLean Kabwe, Ina Kafunda, Adebayo Olufunso, Annie Mwila, Jackson Okuku, Nzali Kancheya, Kennedy Nkwemu, Daliso Mumba, Lottie Hachaambwa, Robb Sheneberger, Natalia Blanco, Marie‐Claude Lavoie, Kristen A. Stafford, Cassidy W. Claassen
Publikováno v:
Journal of the International AIDS Society, Vol 25, Iss S5, Pp n/a-n/a (2022)
Abstract Introduction Transgender and gender‐diverse communities in Zambia are highly vulnerable and experience healthcare differently than cisgender persons. The University of Maryland, Baltimore (UMB) supports projects in Zambia to improve HIV ca
Externí odkaz:
https://doaj.org/article/71f3f321fa9d464cbe1cb44c9c417fec
Autor:
Paul Msanzya Zulu MBChB, Mmed, Mona-Gekanju Toeque MD, MPH, Lottie Hachaambwa MBChB, Lameck Chirwa MSc, Sombo Fwoloshi MBChB, Mmed, Mpanji Siwingwa BSC, MPH, Melody Mbewe MClini.Pharm, Joelle I Rosser MD, Kristen A Stafford MPH, PhD, Brianna Lindsay PhD, Lloyd Mulenga MBChB, PhD, MSc, Cassidy W Claassen MD, MPH
Publikováno v:
Journal of the International Association of Providers of AIDS Care, Vol 20 (2021)
Established antiretroviral therapy (ART) programs in sub-Saharan Africa have well-defined first-and second-line therapies but no standard third-line ART regimen. The impact of third-line ART on patients with multiclass-resistant HIV in resource-limit
Externí odkaz:
https://doaj.org/article/3d67e1454c2c48aa8da9da8fe5f99d71
Autor:
Cassidy W. Claassen, Ina Kafunda, Linah Mwango, Steven Shiyanda, Kirsten Stoebenau, Mona Gekanju-Toeque, Brianna Lindsay, Olufunso Adebayo, Msangwa Sinjani, Callistus Kaayunga, Pappy Kakonda wa Banza, Keith Mweebo, Nzali Kancheya, Kebby Musokotwane, Annie Mwila, Newman Monze, Brooke E. Nichols, Natalia Blanco, Marie-Claude C. Lavoie, Douglas C. Watson, Lottie Hachaambwa, Robb Sheneberger
Publikováno v:
AIDS and Behavior.
Autor:
Nyakulira Kandiwo, Racheal Hapunda, Chitalu Chanda, Madeeha Shams, Mona-Gekanju Toeque, David J. Riedel, Willard Mumbi, Lloyd Mulenga, Cassidy W. Claassen, Sombo Fwoloshi, Lottie Hachaambwa
Publikováno v:
Infectious Diseases in Clinical Practice. 31
Autor:
Mona-Gekanju Toeque, Brianna Lindsay, Paul Msanzya Zulu, Lottie Hachaambwa, Sombo Fwoloshi, Duncan Chanda, Kristen A. Stafford, Francis Mupeta, Mpanji Siwingwa, Melody Mutinta, Lameck Chirwa, David J. Riedel, Cassidy Claassen, Lloyd Mulenga
Publikováno v:
AIDS research and human retroviruses. 38(10)
Antiretroviral therapy (ART) uptake continues to increase across sub-Saharan Africa and emergence of drug-resistant HIV mutations poses significant challenges to management of treatment-experienced patients with virologic failure. In Zambia, new thir
Autor:
Brianna Lindsay, Nasho Nyirongo, Linah Mwango, Mona Gekanju Toeque, Carol Masumba, James Paul Litongola, James Sikanyika, Henry Kabombo, Martin Moyo, Steven Siachibila, James Mudenda, Kalima Tembo, Pawel Olowski, Adebayo Olufunso, Elizabeth Muchinda, Bupe Musonda, Jackson Okuku, Annie Mwila, Clement N Moonga, Michael E Herce, Cassidy W Claassen
Publikováno v:
The lancet. HIV. 10(1)
There are over 23 000 incarcerated people in Zambia, a population which has higher HIV prevalence than the general population yet has no access to HIV prevention. To evaluate the feasibility of HIV pre-exposure prophylaxis (PrEP) implementation in Za
Autor:
Lloyd Mulenga, Sombo Fwoloshi, Paul M Zulu, Joelle I. Rosser, Mona-Gekanju Toeque, Melody Mbewe, Cassidy W. Claassen, Lottie Hachaambwa, Mpanji Siwingwa, Kristen A Stafford, Brianna Lindsay, Lameck Chirwa
Publikováno v:
Journal of the International Association of Providers of AIDS Care, Vol 20 (2021)
Journal of the International Association of Providers of AIDS Care
Journal of the International Association of Providers of AIDS Care
Established antiretroviral therapy (ART) programs in sub-Saharan Africa have well-defined first-and second-line therapies but no standard third-line ART regimen. The impact of third-line ART on patients with multiclass-resistant HIV in resource-limit
Autor:
Mona-Gekanju Toeque, Brianna Lindsay, Paul Msanzya Zulu, Sombo Fwoloshi, Duncan Chanda, Francis Mupeta, Mpanji Siwingwa, Melody Mbewe, Lameck Chirwa, Lottie Hachaambwa, Lloyd Mulenga, Cassidy Claassen
Publikováno v:
Open Forum Infectious Diseases
Background In Zambia, third-line regimens consist of a switch to darunavir/ritonavir (DRV/r) and/or raltegravir (RAL) and/or etravirine (ETV), and as of 2017, dolutegravir (DTG), from a failing second-line therapy.5 We assessed virologic suppression